350 related articles for article (PubMed ID: 15093612)
1. Differential effects of regulator of G protein signaling (RGS) proteins on serotonin 5-HT1A, 5-HT2A, and dopamine D2 receptor-mediated signaling and adenylyl cyclase activity.
Ghavami A; Hunt RA; Olsen MA; Zhang J; Smith DL; Kalgaonkar S; Rahman Z; Young KH
Cell Signal; 2004 Jun; 16(6):711-21. PubMed ID: 15093612
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II-evoked enhanced expression of RGS2 attenuates Gi-mediated adenylyl cyclase signaling in A10 cells.
Li Y; Hashim S; Anand-Srivastava MB
Cardiovasc Res; 2005 Jun; 66(3):503-11. PubMed ID: 15914115
[TBL] [Abstract][Full Text] [Related]
3. Application of RGS box proteins to evaluate G-protein selectivity in receptor-promoted signaling.
Hains MD; Siderovski DP; Harden TK
Methods Enzymol; 2004; 389():71-88. PubMed ID: 15313560
[TBL] [Abstract][Full Text] [Related]
4. Single-cell imaging of intracellular Ca2+ and phospholipase C activity reveals that RGS 2, 3, and 4 differentially regulate signaling via the Galphaq/11-linked muscarinic M3 receptor.
Tovey SC; Willars GB
Mol Pharmacol; 2004 Dec; 66(6):1453-64. PubMed ID: 15383626
[TBL] [Abstract][Full Text] [Related]
5. Recruitment of RGS2 and RGS4 to the plasma membrane by G proteins and receptors reflects functional interactions.
Roy AA; Lemberg KE; Chidiac P
Mol Pharmacol; 2003 Sep; 64(3):587-93. PubMed ID: 12920194
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of melatonin and its downstream effector PKCalpha on subcellular localization of RGS proteins.
Rimler A; Jockers R; Lupowitz Z; Sampson SR; Zisapel N
J Pineal Res; 2006 Mar; 40(2):144-52. PubMed ID: 16441551
[TBL] [Abstract][Full Text] [Related]
7. Endogenous regulator of G protein signaling proteins suppress Galphao-dependent, mu-opioid agonist-mediated adenylyl cyclase supersensitization.
Clark MJ; Neubig RR; Traynor JR
J Pharmacol Exp Ther; 2004 Jul; 310(1):215-22. PubMed ID: 15014136
[TBL] [Abstract][Full Text] [Related]
8. Assays for G-protein-coupled receptor signaling using RGS-insensitive Galpha subunits.
Clark MJ; Traynor JR
Methods Enzymol; 2004; 389():155-69. PubMed ID: 15313565
[TBL] [Abstract][Full Text] [Related]
9. Regulation of RGS mRNAs by cAMP in PC12 cells.
Pepperl DJ; Shah-Basu S; VanLeeuwen D; Granneman JG; MacKenzie RG
Biochem Biophys Res Commun; 1998 Feb; 243(1):52-5. PubMed ID: 9473478
[TBL] [Abstract][Full Text] [Related]
10. Lack of receptor-selective effects of either RGS2, RGS3 or RGS4 on muscarinic M3- and gonadotropin-releasing hormone receptor-mediated signalling through G alpha q/11.
Karakoula A; Tovey SC; Brighton PJ; Willars GB
Eur J Pharmacol; 2008 Jun; 587(1-3):16-24. PubMed ID: 18457830
[TBL] [Abstract][Full Text] [Related]
11. Analysis of regulator of G-protein signaling-2 (RGS-2) expression and function in osteoblastic cells.
Thirunavukkarasu K; Halladay DL; Miles RR; Geringer CD; Onyia JE
J Cell Biochem; 2002; 85(4):837-50. PubMed ID: 11968023
[TBL] [Abstract][Full Text] [Related]
12. Regulator of G protein signaling 4 confers selectivity to specific G proteins to modulate mu- and delta-opioid receptor signaling.
Leontiadis LJ; Papakonstantinou MP; Georgoussi Z
Cell Signal; 2009 Jul; 21(7):1218-28. PubMed ID: 19324084
[TBL] [Abstract][Full Text] [Related]
13. RGS-insensitive G-protein mutations to study the role of endogenous RGS proteins.
Fu Y; Zhong H; Nanamori M; Mortensen RM; Huang X; Lan K; Neubig RR
Methods Enzymol; 2004; 389():229-43. PubMed ID: 15313569
[TBL] [Abstract][Full Text] [Related]
14. Activation of serum response element by D2 dopamine receptor is governed by Gbetagamma-mediated MAPK and Rho pathways and regulated by RGS proteins.
Ho G; Wang Y; Jones PG; Young KH
Pharmacology; 2007; 79(2):114-21. PubMed ID: 17179741
[TBL] [Abstract][Full Text] [Related]
15. Endogenous regulator of g protein signaling proteins reduce {mu}-opioid receptor desensitization and down-regulation and adenylyl cyclase tolerance in C6 cells.
Clark MJ; Traynor JR
J Pharmacol Exp Ther; 2005 Feb; 312(2):809-15. PubMed ID: 15383633
[TBL] [Abstract][Full Text] [Related]
16. S1P receptor signalling and RGS proteins; expression and function in vascular smooth muscle cells and transfected CHO cells.
Hendriks-Balk MC; van Loenen PB; Hajji N; Michel MC; Peters SL; Alewijnse AE
Eur J Pharmacol; 2008 Dec; 600(1-3):1-9. PubMed ID: 18854184
[TBL] [Abstract][Full Text] [Related]
17. Regulators of G-protein signaling 4: modulation of 5-HT1A-mediated neurotransmitter release in vivo.
Beyer CE; Ghavami A; Lin Q; Sung A; Rhodes KJ; Dawson LA; Schechter LE; Young KH
Brain Res; 2004 Oct; 1022(1-2):214-20. PubMed ID: 15353231
[TBL] [Abstract][Full Text] [Related]
18. Allosteric regulation of GAP activity by phospholipids in regulators of G-protein signaling.
Tu Y; Wilkie TM
Methods Enzymol; 2004; 389():89-105. PubMed ID: 15313561
[TBL] [Abstract][Full Text] [Related]
19. Regulator of G-protein signaling (RGS) proteins differentially control chondrocyte differentiation.
Appleton CT; James CG; Beier F
J Cell Physiol; 2006 Jun; 207(3):735-45. PubMed ID: 16489565
[TBL] [Abstract][Full Text] [Related]
20. D2 dopamine receptor-induced sensitization of adenylyl cyclase type 1 is G alpha(s) independent.
Vortherms TA; Nguyen CH; Bastepe M; Jüppner H; Watts VJ
Neuropharmacology; 2006 Apr; 50(5):576-84. PubMed ID: 16376953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
